"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 31 | 33 |
| 1997 | 1 | 36 | 37 |
| 1998 | 0 | 34 | 34 |
| 1999 | 0 | 38 | 38 |
| 2000 | 1 | 39 | 40 |
| 2001 | 1 | 28 | 29 |
| 2002 | 1 | 42 | 43 |
| 2003 | 2 | 35 | 37 |
| 2004 | 2 | 40 | 42 |
| 2005 | 3 | 32 | 35 |
| 2006 | 1 | 32 | 33 |
| 2007 | 3 | 43 | 46 |
| 2008 | 1 | 32 | 33 |
| 2009 | 5 | 31 | 36 |
| 2010 | 6 | 24 | 30 |
| 2011 | 1 | 33 | 34 |
| 2012 | 3 | 19 | 22 |
| 2013 | 0 | 37 | 37 |
| 2014 | 1 | 26 | 27 |
| 2015 | 1 | 32 | 33 |
| 2016 | 5 | 22 | 27 |
| 2017 | 2 | 29 | 31 |
| 2018 | 2 | 17 | 19 |
| 2019 | 2 | 14 | 16 |
| 2020 | 2 | 20 | 22 |
| 2021 | 2 | 15 | 17 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 6 | 8 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Safety of Bivalirudin Use in Critically Ill Children: A Single-Center Experience. Pediatr Crit Care Med. 2026 Oct 01; 27(10):1207-1214.
-
Therapeutic potential of hookworm proteins in promoting regulatory immune responses to modulate Trypanosoma cruzi induced liver inflammation and oxidative stress. Mem Inst Oswaldo Cruz. 2026; 121:e250123.
-
Whole-brain Mapping Reveals Diet-dependent Neuronal Activation and Selective Resistance to Exogenous FGF21. Endocrinology. 2025 12 05; 167(1).
-
Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease. Front Cell Infect Microbiol. 2023; 13:1106315.
-
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):495-500.
-
Cost-effectiveness of bivalirudin in pediatric ventricular assist devices. J Heart Lung Transplant. 2023 03; 42(3):390-397.
-
A novel multi-epitope recombinant protein elicits an antigen-specific CD8+?T cells response in Trypanosoma cruzi-infected mice. Vaccine. 2022 10 26; 40(45):6445-6449.
-
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice. PLoS Negl Trop Dis. 2022 09; 16(9):e0010258.
-
Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
-
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. Vaccine. 2022 06 09; 40(26):3655-3663.